Basic Information

Affiliated programs (koza)

• Graduate School of Medicine, 医科学専攻 がん・幹細胞シグナル, 助教
• Graduate School of Medicine, 医学専攻 がん・幹細胞シグナル, 助教
• Graduate School of Pharmaceutical Sciences, 薬科学専攻 がん・幹細胞シグナル学, 助教

Professional Memberships

• 日本癌学会
• 日本分子生物学会

Academic Degree

• 2007

  M.S. in Pharmaceutical Sciences (Kanazawa University)
• 2010

  Ph.D. in Pharmaceutical Sciences (Kanazawa University)

Academic Resume (Graduate Schools)

• Kanazawa University, Division of Pharmaceutical Chemistry and Biology, 修了
• Kanazawa University, Division of Life Sciences, 修了

Academic Resume (Undergraduate School/Majors)

• Kanazawa University, Department of Pharmaceutical Technochemistry, 卒業

High School

• High School

  Kanazawa Nisui High School

Language of Instruction

• Japanese
• English

ID,URL

• ORCID ID

  0000-0003-4612-6031

• J-Global ID

  201801002498288473

• Researcher number

  50836096

Website(s) (URL(s))

• https://cellfate.infront.kyoto-u.ac.jp/

researchmap URL

• https://researchmap.jp/kenkyo_matsuura

Research

Research Topics, Overview of the research

• Research Topics

  Metabolic regulation of stem cell identity: role of intracellular branched-chain amino acid/keto acid balance in cancer stem cells

• Overview of the research

  My research aims to elucidate how intracellular metabolic reprogramming regulates cancer malignancy and stem cell identity. We have shown that the balance between branched-chain amino acids (BCAAs) and branched-chain keto acids (BCKAs) governs the stemness and malignant properties of triple-negative breast cancer (TNBC). We reported that the activity balance between BCAT1 (a BCAA aminotransferase) and the BCKDH complex controls intracellular BCAA/BCKA dynamics and directly regulates cancer stem cell maintenance and malignant transformation. We are also developing single-cell-level metabolic heterogeneity analyses using the BCAA fluorescence biosensor. Our research would contribute to the development of effective therapeutic strategy against the metabolism-dependent cancer.

Research Areas

• Life sciences, Molecular biology, Cancer Biology, Metabolism, Cell Death

Papers

• Distinct metabolic dependency on BCAA defines cancer stemness and malignancy in human triple-negative breast cancer

  Kenkyo Matsuura; Ririko Shinonaga; Mizuki Yamamoto; Yoshiki Yamamoto; Hsin Chen; Ayaka Maeno; Kayo Okuda; Haruki Inoue; Sota Imotani; John Glushka; Koji Miki; Yukako Watanabe; Mamoru Takada; Hironori Kaji; Jun-ichiro Inoue; Ayuna Hattori; Hiromi Imamur; Takahiro Ito

  Cell Reports, Jul. 2026, Peer-reviewed, Lead author

  
• The CD44/COL17A1 pathway promotes the formation of multilayered, transformed epithelia.

  Kei Kozawa; Miho Sekai; Kenji Ohba; Shoko Ito; Hiroaki Sako; Takeshi Maruyama; Mai Kakeno; Takanobu Shirai; Keisuke Kuromiya; Tomoko Kamasaki; Koki Kohashi; Shinya Tanaka; Susumu Ishikawa; Nanami Sato; Shota Asano; Hironori Suzuki; Nobuyuki Tanimura; Yohei Mukai; Noriko Gotoh; Mishie Tanino; Shinya Tanaka; Ken Natsuga; Tomoyoshi Soga; Tomonori Nakamura; Yukihiro Yabuta; Mitinori Saitou; Takahiro Ito; Kenkyo Matsuura; Makoto Tsunoda; Toyone Kikumori; Tadashi Iida; Yasuyuki Mizutani; Yuki Miyai; Kozo Kaibuchi; Atsushi Enomoto; Yasuyuki Fujita

  Current biology : CB, 26 Jul. 2021, Peer-reviewed

  
• Spironolactone‐induced XPB degradation depends on CDK7 kinase and SCFFBXL18 E3 ligase

  Masanobu Ueda; Kenkyo Matsuura; Hidehiko Kawai; Mitsuo Wakasugi; Tsukasa Matsunaga

  Genes to Cells, Apr. 2019, Peer-reviewed

  
• Dimer-specific immunoprecipitation of active caspase-2 identifies TRAF proteins as novel activators.

  Robeson AC; Lindblom KR; Wojton J; Kornbluth S; Matsuura K

  The EMBO journal, Jun. 2018, Peer-reviewed, Last author, Corresponding author

  
• Activation of disulfide bond cleavage triggered by hydrophobization and lipophilization of functionalized dihydroasparagusic acid

  Fuyuhiko Inagaki; Miyuki Momose; Naoya Maruyama; Kenkyo Matsuura; Tsukasa Matsunaga; Chisato Mukai

  Organic and Biomolecular Chemistry, 2018, Peer-reviewed

  
• Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin

  K. Matsuura; N-J Huang; K. Cocce; L. Zhang; S. Kornbluth

  ONCOGENE, Mar. 2017, Peer-reviewed, Lead author

  
• Fatty acid synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death

  C-S Yang; K. Matsuura; N-J Huang; A. C. Robeson; B. Huang; L. Zhang; S. Kornbluth

  ONCOGENE, Jun. 2015, Peer-reviewed, Lead author

  
• A Network of Substrates of the E3 Ubiquitin Ligases MDM2 and HUWE1 Control Apoptosis Independently of p53

  Manabu Kurokawa; Jiyeon Kim; Joseph Geradts; Kenkyo Matsuura; Liu Liu; Xu Ran; Wenle Xia; Thomas J. Ribar; Ricardo Henao; Mark W. Dewhirst; Wun-Jae Kim; Joseph E. Lucas; Shaomeng Wang; Neil L. Spector; Sally Kornbluth

  SCIENCE SIGNALING, May 2013, Peer-reviewed

  
• Rsk-mediated phosphorylation and 14-3-3 epsilon binding of Apaf-1 suppresses cytochrome c-induced apoptosis

  Jiyeon Kim; Amanda B. Parrish; Manabu Kurokawa; Kenkyo Matsuura; Christopher D. Freel; Joshua L. Andersen; Carrie E. Johnson; Sally Kornbluth

  EMBO JOURNAL, Mar. 2012, Peer-reviewed

  
• Cleavage-mediated activation of Chk1 during apoptosis

  Kenkyo Matsuura; Mitsuo Wakasugi; Katsumi Yamashita; Tsukasa Matsunaga

  JOURNAL OF BIOLOGICAL CHEMISTRY, Sep. 2008, Peer-reviewed, Lead author

  
• DDB1 gene disruption causes a severe growth defect and apoptosis in chicken DT40 cells

  Mitsuo Wakasugi; Kenkyo Matsuura; Atsushi Nagasawa; DongTao Fu; Hiroko Shimizu; Ken-ichi Yamamoto; Shunichi Takeda; Tsukasa Matsunaga

  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Dec. 2007, Peer-reviewed, Lead author

  

Misc.

• Cancer stem cell regulation by histone acylation

  Kenkyo Matsuura

  Igaku no ayumi, May 2020, Invited, Lead author

  
• Ubiquitin ligase UBR5 regulates chemotherapeutic resistance in cancer

  Kenkyo Matsuura; Sally Kornbluth

  Seikagaku, Jun. 2018, Invited, Lead author

  
• Metabolic Regulation of Apoptosis in Cancer

  K. Matsuura; K. Canfield; W. Feng; M. Kurokawa

  INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 327, 2016, Invited, Lead author

  

Presentations

• Tumor heterogeneity of activated branched-chain amino acid metabolism regulates the aggressive nature in human triple-negative breast cancer

  Kenkyo Matsuura; Ririko Shinonaga; Mizuki Yamamoto; Yukako Watanabe; Mamoru Takada; Jun-ichiro Inoue; Ayuna Hattori; Hiromi Imamura; Takahiro Ito

  4D Omics in Development & Disease, 29 Sep. 2025

  
• 細胞内分岐鎖アミノ酸代謝の不均一性によるトリプルネガティブ乳がんの悪性形質の制御機構

  松浦顕教; 篠永りりこ; 山本瑞生; 山本佳輝; Hsin Chen; 前野綾香; 渡辺由佳子; 髙田護; 梶弘典; 井上純一郎; Cong Q. Vu; 新井敏; 服部鮎奈; 今村博臣; 伊藤貴浩

  がんと代謝研究会 2026 at 山中座, 26 Jun. 2026

  
• Unique Metabolic Alteration of Intracellular Branched-Chain Amino Acid Heterogeneity Defines Breast Cancer Malignancy

  Matsuura K.; Shinonaga R.; Yamamoto M.; Watanabe Y.; Takada M.; Inoue J.; Arai S.; Hattori A.; Imamura H.; Ito T.

  The 48th Annual Meeting of the Molecular Biology Society of Japan, 04 Dec. 2025, Invited

  
• Tumor heterogeneity of unique BCAA metabolism regulates the aggressive nature in human triple-negative breast cancer

  Matsuura K.; Shinonaga R.; Yamamoto M.; Watanabe Y.; Takada M.; Inoue J.; Hattori A.; Imamura H.; Ito T.

  The 84th Annual Meeting of the Japanese Cancer Association, 26 Sep. 2025

  
• Heterogeneity of BCAA regulates the aggressiveness in breast cancer

  Kenkyo Matsuura; Itsuki Kuroda; Ririko Shinonaga; Mizuki Yamamoto; Jun-ichiro Inoue; Ayuna Hattori; Hiromi Imamura; Takahiro Ito

  第11回 がんと代謝研究会 in 草津, 29 May 2025

  
• Tumor heterogeneity of activated branched-chain amino acid metabolism regulates the aggressive nature in human triple-negative breast cancer

  Kenkyo Matsuura; Itsuki Kuroda; Ririko Shinonaga; Mizuki Yamamoto; Jun-ichiro Inoue; Ayuna Hattori; Hiromi Imamura; Takahiro Ito

  The 22nd Stem Cell Symposium, 24 May 2025

  
• 腫瘍内分岐鎖アミノ酸不均一性と代謝依存的なトリプルネガティブ乳がん悪性化制御機構についての解析

  松浦 顕教

  第47回 日本分子生物学会年会, 29 Nov. 2024

  
• Activated branched-chain amino acid metabolism regulates the aggressive nature in human triple negative breast cancer

  松浦 顕教

  19th INBS 生命医科学研究所ネットワーク国際シンポジウム, 11 Oct. 2024

  
• 分岐鎖アミノ酸代謝依存的な乳がん悪性化制御機構についての解析

  松浦顕教; 黒田逸月; 篠永りりこ; 山本瑞生; 井上純一郎; 今村博臣; 服部鮎奈; 伊藤貴浩

  第10回 がんと代謝研究会 in 別府, 02 Aug. 2024

  
• Activated branched-chain amino acid metabolism regulates the aggressive nature in human triple negative breast cancer

  Matsuura K; Kondo K; Kuroda I; Nakano T; Shinonaga R; Yamamoto M; Inoue J; Imamura H; Hattori A; Ito T

  82nd JCA, 21 Sep. 2023

  
• Branched-chain amino acid metabolism regulates triple negative breast cancer growth by BCAT1 upregulation

  Kenkyo Matsuura; Itsuki Kuroda; Takato Nakano; Mizuki Yamamoto; Jun-ichiro Inoue; John Glushka; Arthur S. Edison; Hiromi Imamura; Ayuna Hattori; Takahiro Ito

  第45回日本分子生物学会年会, 02 Dec. 2022

  
• Triple negative breast cancer regulation by branched-chain amino acids

  Kenkyo Matsuura; Takato Nakano; Itsuki Kuroda; Mizuki Yamamoto; Jun-ichiro Inoue; John Glushka; Arthur S. Edison; Hiromi Imamura; Ayuna Hattori; Takahiro Ito

  第8回 がんと代謝研究会 in 佐渡, 20 Jul. 2022

  
• Regulation of Programmed Cell Death by Protein Ubiquitylation

  Kenkyo Matsuura

  RSセミナー 岡山大学大学院医歯薬学総合研究科, 07 Apr. 2021, Invited

  
• Dimer-specific immunoprecipitation of active caspase-2 by BiFC/GFP-Trap system identifies TRAF proteins as novel activators

  Kenkyo Matsuura; Alexander C Robeson; Kelly R Lindblom; Jeffrey Wojton; Sally Kornbluth

  MBSJ2018, Nov. 2018

  
• UBR5 ubiquitin ligase downregulates proapoptotic protein MOAP-1 and contributes to cisplatin resistance in ovarian cancer

  Kenkyo Matsuura; Nai-Jia Huang; Kimberly Cocce; Liguo Zhang; Sally Kornbluth

  BMB2015, Dec. 2015

  
• Fatty Acid Synthase inhibition engages a novel caspase-2 regulatory mechanism to induce ovarian cancer cell death

  Kenkyo Matsuura; Chih-Sheng Yang; Nai-Jia Huang; Alexander C Robeson; Bofu Huang; Liguo Zhang; Sally Kornbluth

  MBSJ2014, Nov. 2014

  
• Apoptosis induced by fatty acid synthase inhibition is mediated by caspase-2 and its upstream activator REDD1

  Kenkyo Matsuura; Chih-Sheng Yang; Nai-Jia Huang; Alexander C Robeson; Liguo Zhang; Sally Kornbluth

  Gordon Research Conference; Cell Death, 2014

  
• Mechanistic Studies of Apoptosis Induced by Fatty Acid Synthase Inhibition Identifies a Novel Caspase-2 Activator

  Kenkyo Matsuura

  18th Women's Cancer Research Forum at Duke University, 2013

  
• Apoptosis induced by fatty acid synthase inhibition is mediated by caspase-2 and its upstream activator REDD1

  Kenkyo Matsuura; Chih-Sheng Yang; Nai-Jia Huang; Alexander C Robeson; Liguo Zhang; Kelly R Lindblom; Sally Kornbluth

  Cold Spring Harbor Laboratory Meeting; Cell Death, 2013

  
• Regulation of apoptosis by glucose-induced phosphorylation of caspase-2 isoforms

  Kenkyo Matsuura; Chih-Sheng Yang; Marisa R Buchakjian; Sally Kornbluth

  Gordon Research Conferences; Cell Death, 2012

  
• The role of caspase-dependent Chk1 cleavage during apoptosis

  Kenkyo Matsuura; Mitsuo Wakasugi; Manabu Inobe; Katsumi Yamashita; Tsukasa Matsunaga

  The Keystone Symposia Telomere Biology and DNA Repair, 2009

  
• アポトーシスにおけるChk1の切断と活性化

  Kenkyo Matsuura; Mitsuo Wakasugi; Katsuni Yamashita; Manabu Inobe; Tsukasa Matsunaga

  BMB2008, 2008

  
• Caspase-Dependent Cleavage of Chk1 during Apoptosis

  Kenkyo Matsuura; Mitsuo Wakasugi; Tsukasa Matsunaga

  Ataxia-Telangiectasia Workshop 2008, 2008

  
• Caspase-dependent cleavage and activation of Chk1 during apoptosis

  Kenkyo Matsuura; Mitsuo Wakasugi; Manabu Inobe; Katsumi Yamashita; Tsukasa Matsunaga

  6th 3R Symposium, 2008

  
• DT40細胞におけるDNA損傷ストレスに伴うChk1の切断と分解

  Kenkyo Matsuura; Mitsuo Wakasugi; Tsukasa Matsunaga

  BMB2007, 2007

  
• ニワトリDT40コンディショナルノックアウト細胞を用いたDDB1の機能解析

  Kenkyo Matsuura; Mitsuo Wakasugi; DongTao Fu; Tsukasa Matsunaga

  日本薬学会北陸支部平成18年度第1回総会及び第114回例会, 2006

  
• DDB1 is essential for cell proliferation in vertebrate cells

  Kenkyo Matsuura; DongTao Fu; Mitsuo Wakasugi; Tsukasa Matsunaga

  20th IUBMB International Congress of Biochemistry and Molecular Biology and 11th FAOBMB Congress, 2006

  

Awards

• 27 Sep. 2024

  Kyoto University 4th Research Networking Salon, The Best Poster Award

  Activated branched-chain amino acid metabolism regulates the aggressive nature in human triple-negative breast cancer

  Kenkyo Matsuura

External funds: Kakenhi

• Live imaging and selective isolation of protein post-translational modification with bimolecular fluorescence complementation

  Grant-in-Aid for Scientific Research (C)

  Basic Section 37010:Bio-related chemistry

  Kyoto University

  Kenkyo Matsuura

  From 01 Apr. 2019, To 31 Mar. 2022, Project Closed

  BiFC;GFP nanobody;複合体精製;タンパク質翻訳後修飾;ユビキチン

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-19K05691/
• Chemical approaches to understand the complex mechanism of nucleotide excision repair

  Grant-in-Aid for Scientific Research (B)

  Basic Section 63020:Radiation influence-related

  Kanazawa University

  Tsukasa MATSUNAGA

  From 01 Apr. 2019, To 31 Mar. 2022, Project Closed

  ヌクレオチド除去修復;ケミカルバイオロジー;阻害剤;タンパク質分解誘導剤;近位依存性ビオチン標識法;低分子化合物;DNA損傷プローブ

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-19H04265/
• Study of cancer stem cell maintenance signaling regulation by realtime imaging of cellular amino acid dynamics

  Grant-in-Aid for Scientific Research (C)

  Basic Section 50010:Tumor biology-related

  Kyoto University

  Kenkyo Matsuura

  From 01 Apr. 2022, To 31 Mar. 2025, Project Closed

  乳がん;アミノ酸代謝;BCAA;バイオイメージング;分岐鎖アミノ酸;がん幹細胞;バイオセンサー;アミノ酸;代謝;FRETバイオセンサー

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K07188/

Education

Teaching subject(s)

• From 01 Apr. 2026, To 31 Mar. 2027

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2026, To 31 Mar. 2027

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2026, To 31 Mar. 2027

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2026, To 31 Mar. 2027

  Medicinal Frontier Science Research C

  8408, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2026, To 31 Mar. 2027

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2026, To 31 Mar. 2027

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2026, To 31 Mar. 2027

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2026, To 31 Mar. 2027

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Frontier Science Research C

  8408, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2025, To 31 Mar. 2026

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Medicinal Frontier Science Research C

  8408, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2023, To 31 Mar. 2024

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory 4 : Biochemistry and Microbiology

  A906, Fall, Faculty of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory 4 : Biochemistry and Microbiology

  A906, Fall, Faculty of Pharmaceutical Sciences, 4
• From 01 Apr. 2022, To 31 Mar. 2023

  Medical Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2022, To 31 Mar. 2023

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2

Part-time lecturer

• From 01 Apr. 2026, To 30 Sep. 2026

  がん微小環境治療学

  岡山大学
• From 01 Jul. 2023, To 31 Jul. 2023

  キャリア形成概論III

  金沢大学, 医薬保健研究域・薬学系

Administration

Faculty management (title, position)

• From 01 Oct. 2019

  化学物質管理委員会
• From Apr. 2020, To Apr. 2022

  安全衛生委員会